4.8 Article

PERK/eIF2α signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1210633110

关键词

growth delay; irradiation; acute hypoxia

资金

  1. Dutch Science Organization ZonMW VENI Grant [916.76.158]
  2. Dutch Cancer Society KWF Grants [UM 2010-4714, UM 2012-5506, UM 2008-4068]
  3. Ontario Ministry of Health and Long Term Care
  4. Terry Fox New Frontiers Research Program [PPG09-020005]
  5. Ontario Institute for Cancer Research
  6. Terry Fox Research Institute Selective Therapies Program
  7. Canadian Institute for Health Research Grant [201592]
  8. Terry Fox Foundation/Research Institute
  9. European Union Seventh Framework Programme/METOXIA Project [222741]

向作者/读者索取更多资源

Hypoxia is a common feature of tumors and an important contributor to malignancy and treatment resistance. The ability of tumor cells to survive hypoxic stress is mediated in part by hypoxia-inducible factor (HIF)-dependent transcriptional responses. More severe hypoxia activates endoplasmatic reticulum stress responses, including the double-stranded RNA-activated protein kinase (PKR)-like endoplasmic reticulum kinase (PERK)/eukaryotic initiation factor 2 alpha (eIF2 alpha)-dependent arm of the unfolded protein response (UPR). Although several studies implicate important roles for HIF and UPR in adaption to hypoxia, their importance for hypoxic cells responsible for therapy resistance in tumors is unknown. By using isogenic models, we find that HIF and eIF2 alpha signaling contribute to the survival of hypoxic cells in vitro and in vivo. However, the eIF2 alpha-dependent arm of the UPR is uniquely required for the survival of a subset of hypoxic cells that determine tumor radioresistance. We demonstrate that eIF2 alpha signaling induces uptake of cysteine, glutathione synthesis, and protection against reactive oxygen species produced during periods of cycling hypoxia. Together these data imply that eIF2 alpha signaling is a critical contributor to the tolerance of therapy-resistant cells that arise as a consequence of transient changes in oxygenation in solid tumors and thus a therapeutic target in curative treatments for solid cancers.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据